Jallal Bahija
SEC Form 4 insider trading activity
Jallal Bahija has filed 2 SEC Form 4 filings (3 transaction rows) across 2 companies, including ELV, IMCR, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: May 15, 2026.
On the most recent filing, Jallal Bahija is listed as CHIEF EXECUTIVE OFFICER at Immunocore Holdings plc. Inside the rolling window, Jallal Bahija reported no open-market purchases and 1 open-market sale totaling $371K in IMCR.
Companies traded
Other insiders at ELV
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$371K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Jallal Bahija made?
Jallal Bahija has filed 2 SEC Form 4 filings (3 transaction rows) across 2 companies, including ELV, IMCR since 2026.
Which companies does Jallal Bahija trade?
Jallal Bahija has filed SEC Form 4 disclosures for 2 companies, including ELV, IMCR.
When was Jallal Bahija's most recent SEC Form 4 filing?
Jallal Bahija's most recent SEC Form 4 filing on Tracefour is dated May 15, 2026.
What is Jallal Bahija's total buy and sell value in the current window?
Inside the rolling retention window, Jallal Bahija bought $0 and sold $371K based on SEC Form 4 filings.
What was Jallal Bahija's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 11,474 IMCR shares on 2026-02-18, worth $371K, per SEC Form 4 filings.